117 related articles for article (PubMed ID: 1930270)
41. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
42. Cholinergic systems influence local cerebral glucose use in specific anatomical areas: diisopropyl phosphorofluoridate versus soman.
Churchill L; Pazdernik TL; Cross RS; Giesler MP; Nelson SR; Samson FE
Neuroscience; 1987 Jan; 20(1):329-39. PubMed ID: 3561766
[TBL] [Abstract][Full Text] [Related]
43. Analysis of transmembrane proteins from eukaryotic cells.
Evans RM; Grillo FG; Fink LM
J Supramol Struct; 1979; 12(3):403-17. PubMed ID: 547119
[TBL] [Abstract][Full Text] [Related]
44. Sarin and soman depress [3H]acetylcholine secretion in guinea-pig ileum myenteric plexus.
Alberts P; Ogren VR
Acta Physiol Scand; 1985 Oct; 125(2):347-8. PubMed ID: 4072717
[No Abstract] [Full Text] [Related]
45. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Lett; 2011 May; 202(3):203-8. PubMed ID: 21329748
[TBL] [Abstract][Full Text] [Related]
46. On the development of behavioral tolerance to organophosphates. II: Neurophysiological aspects.
Melchers BP; van Helden HP
Pharmacol Biochem Behav; 1990 Feb; 35(2):321-5. PubMed ID: 2157228
[TBL] [Abstract][Full Text] [Related]
47. Effects of low doses of cholinesterase inhibitors on behavioral performance of robot-tested marmosets.
Wolthuis OL; Groen B; Busker RW; van Helden HP
Pharmacol Biochem Behav; 1995; 51(2-3):443-56. PubMed ID: 7667367
[TBL] [Abstract][Full Text] [Related]
48. Purified and unpurified sodium channels from eel electroplax in planar lipid bilayers.
Recio-Pinto E; Duch DS; Levinson SR; Urban BW
J Gen Physiol; 1987 Sep; 90(3):375-95. PubMed ID: 2443607
[TBL] [Abstract][Full Text] [Related]
49. Paraoxonase activity against nerve gases measured by capillary electrophoresis and characterization of human serum paraoxonase (PON1) polymorphism in the coding region (Q192R).
Kanamori-Kataoka M; Seto Y
Anal Biochem; 2009 Feb; 385(1):94-100. PubMed ID: 18952040
[TBL] [Abstract][Full Text] [Related]
50. Effects of 1,1'-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximes.
Harris LW; Heyl WC; Stitcher DL; Broomfield CA
Biochem Pharmacol; 1978 Mar; 27(5):757-61. PubMed ID: 656114
[No Abstract] [Full Text] [Related]
51. Inhalation apparatus for generating sarin and soman toxic vapors.
Sevelová L; Vachek J; Bajgar J
Acta Medica (Hradec Kralove); 2003; 46(4):157-61. PubMed ID: 14965166
[TBL] [Abstract][Full Text] [Related]
52. Relationship between serum cholinesterase activity and the change in body temperature and motor activity in the rat: a dose-response study of diisopropyl fluorophosphate.
Gordon CJ; Fogelson L
Neurotoxicol Teratol; 1993; 15(1):21-5. PubMed ID: 8459784
[TBL] [Abstract][Full Text] [Related]
53. Selective chromo-fluorogenic detection of DFP (a Sarin and Soman mimic) and DCNP (a Tabun mimic) with a unique probe based on a boron dipyrromethene (BODIPY) dye.
Barba-Bon A; Costero AM; Gil S; Martínez-Máñez R; Sancenón F
Org Biomol Chem; 2014 Nov; 12(43):8745-51. PubMed ID: 25260024
[TBL] [Abstract][Full Text] [Related]
54. Lactoperoxidase-coupled iodination of cardiac sarcoplasmic reticulum proteins.
Louis CF; Katz AM
Biochim Biophys Acta; 1977 Sep; 494(1):255-65. PubMed ID: 901808
[TBL] [Abstract][Full Text] [Related]
55. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of a soman- and diisopropyl phosphorofluoridate (DFP)-detoxifying enzyme by Mipafox.
Hoskin FC
Biochem Pharmacol; 1985 Jun; 34(12):2069-72. PubMed ID: 4004925
[TBL] [Abstract][Full Text] [Related]
57. Acute exposure to a low or mild dose of soman: biochemical, behavioral and histopathological effects.
Baille V; Dorandeu F; Carpentier P; Bizot JC; Filliat P; Four E; Denis J; Lallement G
Pharmacol Biochem Behav; 2001; 69(3-4):561-9. PubMed ID: 11509217
[TBL] [Abstract][Full Text] [Related]
58. [Inhibitory effect of soman on stress induced hyperthermia in rats and the influence of central and peripheral cholinergic antagonists].
Yang YL; Wang YL; Lai Y; Hui J; Li X; Chen XH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):19-23. PubMed ID: 21141547
[TBL] [Abstract][Full Text] [Related]
59. Selective iodination and polypeptide composition of pinocytic vesicles.
Mellman IS; Steinman RM; Unkeless JC; Cohn ZA
J Cell Biol; 1980 Sep; 86(3):712-22. PubMed ID: 7410475
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of reactivation test in anaesthetized dogs with experimental intoxication with nerve agents.
Bajgar J; Fusek J; Bartosova L; Jun D; Kuca K
J Appl Toxicol; 2006; 26(5):439-43. PubMed ID: 16915560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
